Research Library

The authors assess the impact of Mexico's 2014 energy reform on consumer welfare.

It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.

This study leverages validated patient-reported outcomes measures  to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons

This paper presents a stochastic bilevel disjunctive program for transmission investment planning. Published in Networks and Spatial Economics -- A Journal of Infrastructure Modeling and Computation.

To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.

This study presents an integrated framework for hurricane risk assessment of petroleum infrastructure under changing climatic conditions, calculating risk in terms of monetary loss.

This study highlights areas where efforts could be made to address policy issues, institutional barriers and national biases to promote more productive collaboration in the global scientific community.

In this study, the authors found that a parental history of ACEs can weaken protective factors — such as resilience and social connections — that could mitigate the risk of perpetuating the trauma in the next generation.  Children and Youth Services Review: http://bit.ly/2UmOH95

Gene editing in humans raises ethical and safety issues that require further discussion to identify a responsible way forward.

The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report.